Patients and Families

Malignant Hyperthermia (MH) is an inherited muscle disorder triggered by certain types of anesthesia that may cause a fast-acting life-threatening crisis.

The incidence of MH is low, but, if untreated, the mortality rate is high. Great advances in our understanding of MH have been made since it was first recognized in the early 1960s, but the nature of the fundamental defect(s) is still unknown.

 

Frequently Asked Questions

 

MH Registry

The North American Malignant Hyperthermia Registry of MHAUS helps us to understand MH by recording the family health histories and testing results of MH patients and their families and then researching the data. Registry functions are consistent with HIPAA, OHRP, and IRB regulations and data can be used to conduct research.

 

Patient Liaison Committee

The Patient Liaison Committee (PLC) serves the needs of MH-susceptible individuals and their family. The members provide educational materials, access to MH expert consultants, and a support network. It functions as an outreach for one-on-one contacts for individuals who would like to talk to someone with similar experience. The committee members are volunteers who either have MH personally or a family member is MH-susceptible, medical professionals, and others interested in MH. PLC initiatives include: